Daniel B. Smith - Concepedia

Author

Daniel B. Smith

Also Known As

D B SMITH, D B Smith, D Smith, D. B. Smith, D. Smith, D.B. Smith, Daniel B Smith, Daniel B. J. Smith, Daniel B. Smith, Daniel Smith

Publications

2.2K

Citations

H-Index

107

Concepts

All Affiliations

IQVIA (United States)University of South Florida Arsenal Medical (United States)Massachusetts General Hospital Florida College

About

Daniel B. Smith is an author at IQVIA (United States) specializing in medicine, neuropathology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	853
2	Health Sciences	2	2	65
3	Engineering	1	1	147
4	Management	1	1	11
5	Natural Sciences	1	1	10

Daniel B. Smith

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Comparing Adherence and Persistence Across 6 Chronic Medication Classes Jason Yeaw, Joshua S. Benner, John G. Walt, Journal of Managed Care Pharmacy	2009	547
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy Sita Reddy, Daniel B. Smith, Mark M. Rich, Nature Genetics Myotonic Dystrophy ProteinPhysiologyPathologyDegenerative DiseaseNeuropathology	1996	348
Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies Jennie H. Best, Byron J. Hoogwerf, William H. Herman, Diabetes Care	2010	252
<i>In Vivo</i> Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes Sarah Ehlen Haecker, Hansell H. Stedman, Rita J. Balice‐Gordon, Human Gene Therapy Viral ReplicationEngineeringSynthetic VirologyImmunologyGene Delivery	1996	147
Survival and Changes in Comorbidities After Bariatric Surgery Cynthia D. Perry, Matthew M. Hutter, Daniel B. Smith, Annals of Surgery	2008	138
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis Mittermayer B. Santiago, Murray Baron, Kiyomitsu Miyachi, Clinical Rheumatology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseImmunology	2007	100
Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study Madé Wenten, J. A. Gaebler, Mohamed Hussein, Diabetic Medicine	2012	75
Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study Thomas D Gilbert, Daniel B. Smith, Daniel A. Ollendorf BMC Musculoskeletal Disorders	2004	57
Impact of Triiodothyronine on the Survival of High-Risk Patients Undergoing Open Heart Surgery D. Novitzky, Héctor L. Fontanet, Michael Snyder, Cardiology Percutaneous Coronary InterventionHypertensionHeart FailureContinuous T3 InfusionCpb Dependent	1996	51
Impact of infliximab adherence on Crohn’s disease-related healthcare utilization and inpatient costs Chureen T. Carter, Heidi C. Waters, Daniel B. Smith Advances in Therapy Disease ManagementHealthcare ValueChronic Disease ManagementDisease-related Healthcare UtilizationInfliximab Adherence	2011	47

Page 1